Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 13.624\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) NS(=O)(=O)c1ccc(N2CCNCC2)cc1
(b) Cc1ccc(-c2csc(NC(=O)CN3CCOCC3)n2)cc1C
(c) CC1(C)NC(=O)N(CC(O)COc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])C1=O
Answer: b. Cc1ccc(-c2csc(NC(=O)CN3CCOCC3)n2)cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2csc(NC(=O)CN3CCOCC3)n2)cc1C
Cc1ccc(-c2csc(NC(=O)CN3CCOCC3)n2)cc1C
N-[4-(3,4-dimethylphenyl)-1,3-thiazol-2-yl]-2-morpholin-4-ylacetamide